Jeil Pharm (002620) — Long-term Investment Intensity
Jeil Pharm (002620) has a Long-term Investment Intensity of 7.7% as of December 2019. Long-term investments of ₩65.10 Billion represent 7.7% of total assets of ₩846.47 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Jeil Pharm total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Jeil Pharm Long-term Investment Intensity (2011–2019)
This chart shows how Jeil Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2011 to 2019. As of December 2019, the intensity stands at 7.7%, reflecting long-term investments of ₩65.10 Billion against total assets of ₩846.47 Billion KRW. Explore 002620 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Jeil Pharm (2011–2019)
The table below presents the year-by-year Long-term Investment Intensity for Jeil Pharm from 2011 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Jeil Pharm (002620) market capitalisation.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 7.7% | ₩65.10 Billion | ₩846.47 Billion | ▲ +1.1 pp |
| 2018 | 6.6% | ₩60.89 Billion | ₩920.09 Billion | ▼ -63.2 pp |
| 2017 | 69.9% | ₩138.05 Billion | ₩197.59 Billion | ▲ +60.1 pp |
| 2016 | 9.8% | ₩48.24 Billion | ₩491.98 Billion | ▼ -0.8 pp |
| 2015 | 10.6% | ₩46.99 Billion | ₩445.17 Billion | ▼ -1.2 pp |
| 2012 | 11.8% | ₩46.00 Billion | ₩390.77 Billion | ▼ -0.3 pp |
| 2011 | 12.1% | ₩46.30 Billion | ₩384.13 Billion | — |